Navigation Links
Patient Advocate Foundation Announces Additional Support for Patient Co-Pay Relief Program Serving Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Patients
Date:6/3/2011

HAMPTON, Va., June 3, 2011/PRNewswire-USNewswire/ -- Patient Advocate Foundation (PAF) is pleased to announce that it has received a new contribution enabling it to begin offering support to patients suffering with nonsquamous non-small cell lung cancer (NSCLC) through its Co-Pay Relief Program (CPR) on June 6, 2011 at 11:00 AM EDT. PAF is a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability relative to their diagnosis of life threatening or debilitating diseases.

PAF's Co-Pay Relief Program provides direct financial support for pharmaceutical co-payments to insured patients, including Medicare Part D beneficiaries, who financially and medically qualify.  Since the program's inception in April 2004, CPR distributed more than $120 million in assistance to more than 46,000 patients who were unable to afford their pharmaceutical co-payments.

"A debilitating or life-threatening diagnosis can be the most overwhelming experience a person may ever face in his or her lifetime. Coupled with high-cost pharmaceutical co-pay expenses, the journey can become significantly more challenging to manage," said Nancy Davenport-Ennis, Founder and CEO of PAF. "Patient Advocate Foundation created the Co-Pay Relief Program in 2004 after receiving an increased number of patients seeking co-pay assistance for pharmaceutical drugs, so we are particularly pleased to be able to offer assistance to more patients every year."

Globally, lung cancer is the most common form of cancer and the biggest killer, causing 1.3 million cancer deaths annually.  About 85 – 90 percent of all lung cancers are NSCLC. The liver, bones and brain are potential targets if the cancerous cells enter the bloodstream. NSCLC comprises a group of histologies or tumor types differentiated by cellular structure. Nonsquamous histology includes ad
'/>"/>

SOURCE Patient Advocate Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015  Mail-service and specialty pharmacies ... employers and government health plans $23.3 billion over ... the Pharmaceutical Care Management Association (PCMA). ... one of the easiest ways to reduce health ... Merritt . "Policymakers should resist efforts to restrict ...
(Date:2/26/2015)... Feb. 26, 2015 Every year many millions ... fight heart disease.  Nevertheless, year after year doctors and ... as the first test to determine the status of ... pain or not, even though that technology is over ... fact that doctors know, (while most patients do not ...
(Date:2/26/2015)... DUBLIN , Feb. 26, 2015 Research and ... addition of the "Radiation Therapy Equipment - Global ... This report analyzes the worldwide markets for ... Product Segments: Linear Accelerator, Treatment Planning Systems, and Radiation ... the US, Canada , ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2National Heart Health Month In February 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2
... 2011 Reportlinker.com announces that a new market research report ... Products http://www.reportlinker.com/p060973/Cosmetic-Surgery-Products.html ... Demand for products used in cosmetic surgery is forecast ... 2014, when 16.1 million cosmetic procedures are expected to be ...
... 2011 Medco Health Solutions, Inc. (NYSE: MHS ... to present at the following healthcare conferences: (Logo: ... CEOs Unscripted conference taking place in New York at the ... 8:45 a.m. ET; The 29th Annual JPMorgan ...
Cached Medicine Technology:Reportlinker Adds Cosmetic Surgery Products 2Reportlinker Adds Cosmetic Surgery Products 3Medco CEO to Present at Upcoming Healthcare Conferences 2
(Date:2/27/2015)... Sunnyvale, CA (PRWEB) February 27, 2015 ... showcase ClinCapture, its validated Electronic Data Capture (EDC) at ... Francisco, California on March 2nd and March 3rd at ... a self-service platform and DIY CRF and edit-check builder ... Checks in a matter of days, without any programming ...
(Date:2/27/2015)... 2015 Altec Products, Inc., announced today ... ERP Document Management Partner of the Year. ADSS Global ... and other complimentary solutions for their customers across the ... many years to provide clients with paperless solutions that ... “We are thrilled to recognize ADSS Global for their ...
(Date:2/27/2015)... In honor of American Heart Month in February, ... office, is offering tips on how to improve heart health. , ... doesn't mean people have to accept it as their fate. Although ... such as family history, sex or age — there are some ... has six helpful tips to improve heart health and prevent heart ...
(Date:2/27/2015)... 2015 Undocumented farmworkers are half ... use Medicaid, the federal health insurance program available ... new study from UC Davis Health System. The ... farmworker use of Medicaid, which provides coverage for ... status, was having children. , “Undocumented agricultural ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The federal ... ) that allege use of the statin medication can ... has issued a new order pertaining discovery in the ... Bernstein Liebhard LLP comments. The Order, which was issued ... on February 25th, directs the parties to schedule certain ...
Breaking Medicine News(10 mins):Health News:Clinovo to Demo Its Self-Service, Cloud-Based EDC Solution at CALBIO2015 on March 2nd and 3rd, 2015 2Health News:Altec Announces 2014 Sage ERP Document Management Partner of the Year Award Recipient 2Health News:Center for Primary Care Celebrates American Heart Month 2Health News:Center for Primary Care Celebrates American Heart Month 3Health News:Center for Primary Care Celebrates American Heart Month 4Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 2Health News:UC Davis Study Finds Undocumented Farmworkers Use Medicaid Half as Often as Documented Farmworkers 3Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3
... While the visual regions of the brain have been ... uncharted territory. Now, researchers at the Hebrew University of ... a key auditory process perceiving sound space, the ... concentrating on those sounds. , The findings settle ...
... MEDIA, Pa., Sept. 20 Synova Healthcare Group,Inc. (OTC ... sale,of approximately $3.3 million in aggregate notional principal amount ... September 19, 2012,and related common stock purchase warrants. This ... private placement of notes and warrants in the,aggregate notional ...
... Philadelphia, PA, September 20, 2007 Pedophilia, the sexual ... health concern and it does not respond well to ... not well understood. A new study being published ... the first of its kind to use functional brain ...
... Calif., Sept. 20 Cardiva Medical, Inc.,a privately ... Chairman and CEO, will present at the UBS ... in New York City. Notably, the,company will be ... the,Boomerang Catalyst II System, which recently received a ...
... 19, 2007 -- A single dose of Otsukas ... resulted in favorable changes in hemodynamics associated with ... with advanced heart failure (ADHF) who participated in ... HemodynamIc Parameters in Subjects with HEart failure (ECLIPSE), ...
... Speaker Nancy Pelosi,issued the following statement today on ... a vote of 405 to 7:, "Today,s sweeping, ... all Americans., "Essential to the safety net of ... that the prescription drugs they buy are safe. These ...
Cached Medicine News:Health News:Sensitivity of brain center for 'sound space' defined 2Health News:Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants 2Health News:Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants 3Health News:Pedophilia patients are found to have deficits in brain activation 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 2Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 3Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 4Health News:Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM) 5Health News:ECLIPSE data on effects of Otsuka's investigational novel treatment, Tolvaptan 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: